Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Thromboembolism and Clinically Relevant Bleeding in Relation to Warfarin Anticoagulation Variability in Patients Monitored with Either Fiix-Prothrombin Time or Quick-Prothrombin Time. the Fiix-Trial

Alma R. Oskarsdottir, BS, Brynja R. Gudmundsdottir, MS, Olafur S. Indridason, MD MPH, Hulda M. Jensdottir, BS, David O. Arnar, MD PhD, Einar S. Bjornsson, MD PhD, Magnus K. Magnusson, MD, Sigrun H. Lund, PhD, Brynjar Vidarsson, MD, Charles W. Francis, MD, Pall T. Onundarson, MD

Blood (2015) 126 (23): 1129.

https://doi.org/10.1182/blood.V126.23.1129.1129

Published: 2015

Journal Articles

Gender Differences during Long-Term Warfarin Anticoagulation in Patients with Atrial Fibrillation Monitored with Fiix-Prothrombin Time or Prothrombin Time. the Fiix Trial

Hulda M. Jensdottir, BS, Brynjar Vidarsson, MD, Brynja R. Gudmundsdottir, MS, Alma R. Oskarsdottir, BS, Olafur S. Indridason, MD MPH, David O. Arnar, MD PhD, Einar S. Bjornsson, MD PhD, Magnus K. Magnusson, MD, Sigrun H. Lund, PhD, Charles W. Francis, MD, Pall T. Onundarson, MD

Blood (2015) 126 (23): 1134.

https://doi.org/10.1182/blood.V126.23.1134.1134

Published: 2015

Journal Articles

Monitoring Warfarin with the Fiix-Prothrombin Time Improves Anticoagulation Stability and Long-Term Clinical Outcome. the Fiix-Trial

Pall T. Onundarson, MD, Charles W. Francis, MD, Einar S. Bjornsson, MDPhD, Magnus K. Magnusson, MD, David O. Arnar, MD, Olafur S. Indridason, MD, Sigrun Helga Lund, PhD, Sigurdur J. Juliusson, BS, Hulda M. Jensdottir, Brynja R. Gudmundsdottir, MS

Blood (2014) 124 (21): 347.

https://doi.org/10.1182/blood.V124.21.347.347

Published: 2014

Journal Articles

Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.

Blood (2007) 110 (11): 4559.

https://doi.org/10.1182/blood.V110.11.4559.4559

Published: 2007

Journal Articles

Bernard-Soulier in Iceland. Bleeding Symptoms and Platelet Parameters in Patients, Carriers and Controls.

Pall Torfi Onundarson, MD, Elisabet R. Birgisdottir, MS, Gudrun Bragadottir, Bylgja Hilmarsdottir, Brynja Gudmundsdottir, MS, Brynjar Vidarsson, MD, Magnus K. Magnusson, MD

Blood (2006) 108 (11): 1095.

https://doi.org/10.1182/blood.V108.11.1095.1095

Published: 2006

Journal Articles

Regulatory Role of the Sprouty Gene Family on PDGFβR Fusion Oncogenes.

Silja D. Andradottir, BS, Magnus K. Magnusson, MD

Blood (2005) 106 (11): 3509.

https://doi.org/10.1182/blood.V106.11.3509.3509

Published: 2005

Journal Articles

Proliferation of CD8 + T-Cells Specific for CMV and EBV in Response to TCR Mediated Recognition of Cognate Antigen Is Inhibited by Imatinib in a Dose-Dependent Manner.

Ruth Seggewiss, MD, Karin Lore, PhD, Elisabeth Greiner, PhD, Magnus K. Magnusson, MD, David A. Price, MD PhD, Daniel C. Douek, MD PhD, Cynthia E. Dunbar, MD, Adrian Wiestner, MD PhD

Blood (2004) 104 (11): 1342.

https://doi.org/10.1182/blood.V104.11.1342.1342

Published: 2004

NARROW

Thromboembolism and Clinically Relevant Bleeding in Relation to Warfarin Anticoagulation Variability in Patients Monitored with Either Fiix-Prothrombin Time or Quick-Prothrombin Time. the Fiix-Trial

Gender Differences during Long-Term Warfarin Anticoagulation in Patients with Atrial Fibrillation Monitored with Fiix-Prothrombin Time or Prothrombin Time. the Fiix Trial

Monitoring Warfarin with the Fiix-Prothrombin Time Improves Anticoagulation Stability and Long-Term Clinical Outcome. the Fiix-Trial

Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.

Bernard-Soulier in Iceland. Bleeding Symptoms and Platelet Parameters in Patients, Carriers and Controls.

Regulatory Role of the Sprouty Gene Family on PDGFβR Fusion Oncogenes.

Proliferation of CD8 + T-Cells Specific for CMV and EBV in Response to TCR Mediated Recognition of Cognate Antigen Is Inhibited by Imatinib in a Dose-Dependent Manner.

Email alerts

ASH Publications

American Society of Hematology

Thromboembolism and Clinically Relevant Bleeding in Relation to Warfarin Anticoagulation Variability in Patients Monitored with Either Fiix-Prothrombin Time or Quick-Prothrombin Time. the Fiix-Trial

Gender Differences during Long-Term Warfarin Anticoagulation in Patients with Atrial Fibrillation Monitored with Fiix-Prothrombin Time or Prothrombin Time. the Fiix Trial

Monitoring Warfarin with the Fiix-Prothrombin Time Improves Anticoagulation Stability and Long-Term Clinical Outcome. the Fiix-Trial

Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.

Bernard-Soulier in Iceland. Bleeding Symptoms and Platelet Parameters in Patients, Carriers and Controls.

Regulatory Role of the Sprouty Gene Family on PDGFβR Fusion Oncogenes.

Proliferation of CD8 + T-Cells Specific for CMV and EBV in Response to TCR Mediated Recognition of Cognate Antigen Is Inhibited by Imatinib in a Dose-Dependent Manner.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only